Rabbit Polyclonal DLST antibody. Suitable for IHC-Fr, IHC-P, IP, WB and reacts with Human, Mouse samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human DLST aa 50-100.
View Alternative Names
DLTS, DLST, 2-oxoglutarate dehydrogenase complex component E2, Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex, E2K, OGDC-E2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DLST antibody (AB187699)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded human ovarian carcinoma tissue labeling DLST with ab187699 at a 1/1000 dilution.
- IHC-Fr
Supplier Data
Immunohistochemistry (Frozen sections) - Anti-DLST antibody (AB187699)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded human lung cancer tissue labeling DLST with ab187699 at a 1/1000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-DLST antibody (AB187699)
Detection of DLST by Western Blot of Immunprecipitate.
Lane 1 : ab187699 at 1 μg/ml labeling DLST in Jurkat whole cell lysate immunoprecipitated using ab187699 at 6μg/mg lysate (1 mg/IP; 20% of IP loaded/lane).
Lane 2 : Control IgG
Detection : Chemiluminescence with exposure time of 3 seconds.
All lanes:
Immunoprecipitation - Anti-DLST antibody (ab187699)
Predicted band size: 49 kDa
false
- WB
Supplier Data
Western blot - Anti-DLST antibody (AB187699)
All lanes:
Western blot - Anti-DLST antibody (ab187699) at 0.1 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
293T whole cell lysate at 50 µg
Lane 3:
Jurkat whole cell lysate at 50 µg
Lane 4:
TCMK-1 cell lysate at 50 µg
Lane 5:
NIH3T3 whole cell lysate at 50 µg
Predicted band size: 49 kDa
true
Exposure time: 30s
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The DLST enzyme acts within the tricarboxylic acid (TCA) cycle also known as the Krebs cycle or citric acid cycle. It forms a critical part of the multi-enzyme complex OGDC facilitating the oxidative decarboxylation of 2-oxoglutarate an important step in the TCA cycle. Through this action DLST helps produce succinyl-CoA a molecule pivotal for energy and biosynthetic processes. The activity of this protein ensures continuous energy supply and intermediary metabolite flow within cellular respiration.
Pathways
DLST plays a significant role within both the TCA cycle and the broader metabolic pathway of oxidative phosphorylation. These are important for efficient cellular energy production connecting many metabolic reactions and facilitating ATP generation. OGDC where DLST performs its function interacts with various proteins such as E1 (2-oxoglutarate dehydrogenase) and E3 (dihydrolipoamide dehydrogenase). This interaction is necessary to efficiently process and interconvert energy substrates for cellular use.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
The Journal of biological chemistry 299:105333 PubMed37827290
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature chemical biology 19:265-274 PubMed36266351
2022
Applications
Unspecified application
Species
Unspecified reactive species
Metabolism: clinical and experimental 114:154416 PubMed33137378
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 129:4708-4723 PubMed31393856
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature immunology 16:415-25 PubMed25706746
2015
Applications
WB
Species
Mouse
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com